fda shortage semaglutide injection resolved feb 21 2025 Hims & Hers stock falls 25% as curtails compounded GLP-1s Semaglutide taken off FDA's drug
Description
Rybelsus Oral tablet for type 2 diabetes

Market impact: intensifies competition with LillyDirect/NovoCare and retailers (Walmart), pushed Eli Lilly and Novo Nordisk shares lower and weighed on related obesitydrug stocks

Today's GLP-1s work to help people lose weight because they mimic a hormone our small intestine makes naturally, which regulates hunger in several different key ways

This lifts the subcutaneous layer away from the underlying muscle, ensuring the needle reaches the right depth

2019;2(3):e00076

Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: results from the International Diabetes Federation Diabetes Atlas, 9(th) edition
